Kate Rochlin - 21 Jun 2023 Form 4 Insider Report for IN8BIO, INC. (INAB)

Role
Chief Operating Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
INAB
Transactions as of
21 Jun 2023
Transactions value $
$0
Form type
4
Filing time
23 Jun 2023, 18:27:50 UTC
Previous filing
18 Apr 2023
Next filing
15 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INAB Employee Stock Option (right to buy) Award $0 +67,800 $0 67,800 21 Jun 2023 Common Stock 67,800 $2.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the shares subject to the option shall vest on June 21, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.